• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.

作者信息

Davidson R N, Russo R

出版信息

Clin Infect Dis. 1994 Sep;19(3):560. doi: 10.1093/clinids/19.3.560.

DOI:10.1093/clinids/19.3.560
PMID:7811891
Abstract
摘要

相似文献

1
Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.感染人类免疫缺陷病毒且接受脂质体两性霉素B治疗的患者内脏利什曼病复发情况
Clin Infect Dis. 1994 Sep;19(3):560. doi: 10.1093/clinids/19.3.560.
2
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.脂质体两性霉素 B 治疗人免疫缺陷病毒合并内脏利什曼病患者：印度比哈尔邦的 2 年治疗结局。
Clin Infect Dis. 2011 Oct;53(7):e91-8. doi: 10.1093/cid/cir521.
3
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.印度对合并感染人类免疫缺陷病毒的内脏利什曼病患者的联合治疗。
Clin Infect Dis. 2015 Oct 15;61(8):1255-62. doi: 10.1093/cid/civ530. Epub 2015 Jun 30.
4
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.尽管免疫缺陷程度可忽略不计，但在人类免疫缺陷病毒（HIV）感染期间仍发生了内脏利什曼病的弥漫性皮肤播散：脂质体两性霉素B给药多次失败，随后成功长期给予喷他脒和巴龙霉素。
Int J Antimicrob Agents. 2008 Jun;31(6):590-2. doi: 10.1016/j.ijantimicag.2008.02.007. Epub 2008 May 5.
5
Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.脂质体两性霉素B治疗合并人类免疫缺陷病毒感染患者内脏利什曼病的疗效
Clin Infect Dis. 1995 Jan;20(1):191. doi: 10.1093/clinids/20.1.191.
6
Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.关于《脂质体两性霉素B对HIV感染患者内脏利什曼病二级预防的疗效》的评论
J Antimicrob Chemother. 2008 Feb;61(2):466-7; author reply 467. doi: 10.1093/jac/dkm478. Epub 2007 Dec 11.
7
[Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)].[与人类免疫缺陷病毒感染相关的内脏利什曼病（回复）]
Enferm Infecc Microbiol Clin. 2002 Mar;20(3):133. doi: 10.1016/s0213-005x(02)72766-3.
8
Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.一名患有晚期疾病的HIV-1感染患者出现复发性内脏利什曼病。
Acta Clin Belg. 2013 Mar-Apr;68(2):124-7. doi: 10.2143/ACB.3207.
9
Liposomal amphotericin B for the treatment of visceral leishmaniasis.脂质体两性霉素B用于治疗内脏利什曼病。
Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28.
10
Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?脂质体两性霉素 B 治疗苏丹东部复杂内脏利什曼病（黑热病）：这种被忽视疾病的治疗效果如何？
Trop Med Int Health. 2014 Feb;19(2):146-52. doi: 10.1111/tmi.12238. Epub 2014 Jan 17.

引用本文的文献

1
Availability, Toxicology and Medical Significance of Antimony.锑的可用性、毒理学和医学意义。
Int J Environ Res Public Health. 2022 Apr 12;19(8):4669. doi: 10.3390/ijerph19084669.
2
Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.锑剂用于治疗对脂质体两性霉素B无反应的内脏利什曼病。
PLoS Negl Trop Dis. 2016 Jan 6;10(1):e0004304. doi: 10.1371/journal.pntd.0004304. eCollection 2016 Jan.
3
Clinical use of anti-TNF therapy and increased risk of infections.抗TNF治疗的临床应用与感染风险增加
Drug Healthc Patient Saf. 2013;5:79-99. doi: 10.2147/DHPS.S28801. Epub 2013 Mar 28.
4
Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.HIV 感染者的寄生虫感染：诊断和治疗挑战。
Indian J Med Res. 2011 Dec;134(6):878-97. doi: 10.4103/0971-5916.92633.
5
Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.HIV 感染者内脏利什曼病复发的预测因素：系统评价。
PLoS Negl Trop Dis. 2011 Jun;5(6):e1153. doi: 10.1371/journal.pntd.0001153. Epub 2011 Jun 7.
6
Noninvasive method for diagnosis of visceral leishmaniasis by a latex agglutination test for detection of antigens in urine samples.通过乳胶凝集试验检测尿液样本中的抗原用于内脏利什曼病诊断的非侵入性方法。
J Clin Microbiol. 2004 Apr;42(4):1853-4. doi: 10.1128/JCM.42.4.1853-1854.2004.
7
Pyrexia of undetermined origin in advanced HIV disease.晚期HIV疾病中的不明原因发热。
Genitourin Med. 1997 Aug;73(4):308-13. doi: 10.1136/sti.73.4.308.
8
Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.两性霉素B不同制剂对小鼠内脏利什曼病疗效的比较。
Antimicrob Agents Chemother. 1997 Oct;41(10):2089-92. doi: 10.1128/AAC.41.10.2089.
9
Leishmania and human immunodeficiency virus coinfection: the first 10 years.利什曼原虫与人类免疫缺陷病毒合并感染：头十年
Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298.
10
Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.脂质体两性霉素B对实验性皮肤利什曼病的活性。
Antimicrob Agents Chemother. 1997 Apr;41(4):752-6. doi: 10.1128/AAC.41.4.752.